Stock Price
49.50
Daily Change
-0.55 -1.10%
Monthly
6.96%
Yearly
0.08%
Q2 Forecast
48.22

Recordati reported EUR171.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Orion EUR 91.9M 18.8M Mar/2026
Sanofi EUR 2.33B 419M Mar/2026